To improve lives in Africa and Asia through sustainable, evidence-based programmes that combat targeted diseases and promote child and maternal health.
Malaria Consortium works on preventing, controlling, and treating malaria and other communicable diseases in Africa and Asia. GiveWell has only reviewed its seasonal malaria chemoprevention (SMC) program, which aims to distribute preventive anti-malarial drugs to children 3-months to 59-months old in order to prevent illness and death from malaria. There is strong evidence that SMC substantially reduces cases of malaria. GiveWell's recommendation is just for the SMC part of Malaria Consortium's work.
Where they work:
Burkina Faso | Chad | Ethiopia | Mozambique | Nigeria | South Sudan | Sierra Leone | Uganda
Cambodia | Myanmar | Thailand
What do they do?
Malaria Consortium's uniqueness is in their ability to consistently design and apply tailored, technically excellent, evidence-based solutions, fit for effective implementation, with impact on the wide health system and economy.
Specializing in the comprehensive control of malaria & other communicable diseases
Malaria control is central to Malaria Consortium's strategy.
Also undertakes complementary work on child health, including:
- integrated community case management of childhood illness,
- nutrition and
- the control of NTDs.
Particularly children under five years old; also pregnant women & migrant populations.
Main areas of impact:
- Childhood diseases
- + preventable blindness
- + nutrition
- Seasonal chemotherapy
Why are they recommended?
Malaria Consortium is recommended by GiveWell.